Meis Omran

7PUBLICATIONS
23CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersCancer geneticsTe hauora mamao o te Māori (Māori remote health)Ngā pūtaiao koiora-hauora, haumanu hoki o te Māori (Māori biomedical and clinical sciences)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 02, 2026
Digital Health Tools Embedded in a Cancer Genetics Clinic: Observational Study.

Sujay Nagaraj, Ron Rabinowicz, Sarah Goodday

|Jun 21, 2025
The argument for screening programs in previvors with Li-Fraumeni syndrome.

Meis Omran, David Malkin

|Feb 06, 2025
Limiting surveillance in individuals with the Palestinian TP53 p. R181C founder variant-is it too soon to draw conclusions?

Meis Omran, David Malkin

|Jan 05, 2025
Characterisation of heritable TP53-related cancer syndrome in Sweden-a nationwide study of genotype-phenotype correlations in 90 families.

Meis Omran, Yaxuan Liu, Alexander Sun Zhang

|Jan 05, 2023
Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study.

Meis Omran, Hemming Johansson, Claudia Lundgren

|Jan 21, 2022
Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary <i>TP53</i>-Related Cancer Syndrome Study (SWEP53).

Meis Omran, Emma Tham, Yvonne Brandberg

Pageof 2

Frequent Collaborators

3 joint publications

Emma Tham

3 joint publications

Svetlana Bajalica-Lagercrantz

3 joint publications

David Malkin

2 joint publications

Anna Rosén